Company / Working Capital
Fortress Biotech, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$74.1M
FY2025
5-year range
$19.0M / $245.4M
FY2021-FY2025
Trend
+290.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed +291% YoY in FY2025, a notable deviation from the 9-year average annual change of +46%.
Based on SEC 10-K filings.
$74M in FY2025 with a 5-year CAGR of -7.7%.
Improved from $32M to $74M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -10.3%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.7%, indicating a declining trend.
- In FY2025, working capital increased 290.6% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.1M | +290.6% |
| FY2024 | $19.0M | -40.9% |
| FY2023 | $32.1M | -68.7% |
| FY2022 | $102.7M | -58.1% |
| FY2021 | $245.4M | +121.8% |
| FY2020 | $110.6M | +0.0% |
| FY2019 | $110.6M | +99.0% |
| FY2018 | $55.6M | -52.0% |
| FY2017 | $115.8M | +118.1% |
| FY2016 | $53.1M | -40.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026